r 30, 2010 was $24,438 million, which included total segment revenue of $24,442 million and Corporate revenue of $(4) million. Corporate revenue consists primarily of elimination of inter-segment revenue.Total consolidated operating earnings for the three months ended September 30, 2011 were $412 million, which included total segment profit of $442 million and Corporate costs of $(30) million. Total consolidated operating earnings for the three months ended September 30, 2010 were $364 million, which included total segment profit of $390 million and Corporate costs of $(26) million. Corporate includes, among other things, restructuring and employee severance, acquisition-related costs, impairments and loss on sale of assets, litigation (recoveries)/charges, net and certain investment spending that are not allocated to the segments.Schedule 6CARDINAL HEALTH, INC. AND SUBSIDIARIESSCHEDULE OF NOTABLE ITEMSFirst Quarter(in millions, except per Common Share amounts)20122011Restructuring and Employee SeveranceRestructuring and employee severance
$ (3.4)$
(1.8)Tax benefit
1.30.6Restructuring and employee severance, net of tax
$ (2.1)$
(1.2)Decrease to diluted EPS from continuing operations
$ (0.01)$
-Acquisition-Related CostsAmortization of acquisition-related intangible assets
$ (18.9)$
(10.3)Tax benefit
6.43.8Amortization of acquisition-related intangible assets, net of tax
$ (12.5)$
(6.5)Decrease to diluted EPS from continuing operations
$ (0.04)$
(0.02)Other acquisition-related costs
$ (8.6)$
(1.3)Tax benefit
3.00.2Other acquisition-related costs, net of tax
$ (5.6)$
(1.1)Decrease to diluted EPS from continuing operations
$ (0.02)$
-Total acquisition-related costs (1)
$ (27.4)$
(11.7)Tax benefit (1)
9.44.0Total acquisition-related costs, net of tax (1)
$ (18.
'/>"/>
SOURCE Cardinal Health Copyright©2010 PR Newswire. All rights reserved | |
Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 Related medicine technology :1.
Cardinal Health Foundation, The Ohio State University Launch New Toolkit to Help Reduce Misuse of Prescription Drugs2.
Cardinal Health to Release First-quarter Financial Results on Oct. 273.
Cardinal Health Introduces New Latex, Powder-Free, Hydrogel Surgical Gloves4.
Polymedco, Inc., and Cardinal Health Sign Agreement for Distribution of Oncologic Diagnostic Test Kits to Acute Care Market5.
Cardinal Health Board of Directors Approves Cash Dividend, Elects David P. King as Director6.
Nearly 7,000 Participate in Cardinal Healths Largest-Ever Annual Trade Show for Independent Pharmacies7.
Cardinal Health to Release Fourth-quarter and Full-year Results for Fiscal Year 2011 on Aug. 48.
Cardinal Health, Prime Therapeutics Renew Primary Distribution Agreement9.
Cardinal Health Extends Radiopharmaceutical Manufacturing Network, Opening its First Cyclotron in Georgia10.
Cardinal Health Supports Future Pharmacists with $1.1 Million Pharmacy Scholarship Program11.
Cardinal Health Raises Quarterly Dividend By 10 Percent